These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 17373721

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Dynamic structure of the SPANX gene cluster mapped to the prostate cancer susceptibility locus HPCX at Xq27.
    Kouprina N, Pavlicek A, Noskov VN, Solomon G, Otstot J, Isaacs W, Carpten JD, Trent JM, Schleutker J, Barrett JC, Jurka J, Larionov V.
    Genome Res; 2005 Nov; 15(11):1477-86. PubMed ID: 16251457
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A major locus for hereditary prostate cancer in Finland: localization by linkage disequilibrium of a haplotype in the HPCX region.
    Baffoe-Bonnie AB, Smith JR, Stephan DA, Schleutker J, Carpten JD, Kainu T, Gillanders EM, Matikainen M, Teslovich TM, Tammela T, Sood R, Balshem AM, Scarborough SD, Xu J, Isaacs WB, Trent JM, Kallioniemi OP, Bailey-Wilson JE.
    Hum Genet; 2005 Aug; 117(4):307-16. PubMed ID: 15906096
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Linkage analysis of 153 prostate cancer families over a 30-cM region containing the putative susceptibility locus HPCX.
    Lange EM, Chen H, Brierley K, Perrone EE, Bock CH, Gillanders E, Ray ME, Cooney KA.
    Clin Cancer Res; 1999 Dec; 5(12):4013-20. PubMed ID: 10632333
    [Abstract] [Full Text] [Related]

  • 10. Confirmation of the prostate cancer susceptibility locus HPCX in a set of 104 German prostate cancer families.
    Bochum S, Paiss T, Vogel W, Herkommer K, Hautmann R, Haeussler J.
    Prostate; 2002 Jun 01; 52(1):12-9. PubMed ID: 11992616
    [Abstract] [Full Text] [Related]

  • 11. Expression of SPANX proteins in normal prostatic tissue and in prostate cancer.
    Salemi M, Calogero AE, Zaccarello G, Castiglione R, Cosentino A, Campagna C, Vicari E, Rappazzo G.
    Eur J Histochem; 2010 Jun 01; 54(3):e41. PubMed ID: 20839415
    [Abstract] [Full Text] [Related]

  • 12. Genome linkage screen for prostate cancer susceptibility loci: results from the Mayo Clinic Familial Prostate Cancer Study.
    Cunningham JM, McDonnell SK, Marks A, Hebbring S, Anderson SA, Peterson BJ, Slager S, French A, Blute ML, Schaid DJ, Thibodeau SN, Mayo Clinic, Rochester, Minnesota.
    Prostate; 2003 Dec 01; 57(4):335-46. PubMed ID: 14601030
    [Abstract] [Full Text] [Related]

  • 13. A shared promoter region suggests a common ancestor for the human VCX/Y, SPANX, and CSAG gene families and the murine CYPT family.
    Hansen MA, Nielsen JE, Retelska D, Larsen N, Leffers H.
    Mol Reprod Dev; 2008 Feb 01; 75(2):219-29. PubMed ID: 17342728
    [Abstract] [Full Text] [Related]

  • 14. BCoR-L1 variation and breast cancer.
    Lose F, Arnold J, Young DB, Brown CJ, Mann GJ, Pupo GM, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Khanna KK, Chenevix-Trench G, Spurdle AB.
    Breast Cancer Res; 2007 Feb 01; 9(4):R54. PubMed ID: 17697391
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: frequent HPCX linkage in families with late-onset disease.
    Schleutker J, Matikainen M, Smith J, Koivisto P, Baffoe-Bonnie A, Kainu T, Gillanders E, Sankila R, Pukkala E, Carpten J, Stephan D, Tammela T, Brownstein M, Bailey-Wilson J, Trent J, Kallioniemi OP.
    Clin Cancer Res; 2000 Dec 01; 6(12):4810-5. PubMed ID: 11156239
    [Abstract] [Full Text] [Related]

  • 17. Genome-wide scan for prostate cancer susceptibility genes in the Johns Hopkins hereditary prostate cancer families.
    Xu J, Gillanders EM, Isaacs SD, Chang BL, Wiley KE, Zheng SL, Jones M, Gildea D, Riedesel E, Albertus J, Freas-Lutz D, Markey C, Meyers DA, Walsh PC, Trent JM, Isaacs WB.
    Prostate; 2003 Dec 01; 57(4):320-5. PubMed ID: 14601028
    [Abstract] [Full Text] [Related]

  • 18. Genomic organization, incidence, and localization of the SPAN-x family of cancer-testis antigens in melanoma tumors and cell lines.
    Westbrook VA, Schoppee PD, Diekman AB, Klotz KL, Allietta M, Hogan KT, Slingluff CL, Patterson JW, Frierson HF, Irvin WP, Flickinger CJ, Coppola MA, Herr JC.
    Clin Cancer Res; 2004 Jan 01; 10(1 Pt 1):101-12. PubMed ID: 14734458
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prohibitin mutations are uncommon in prostate cancer families linked to chromosome 17q.
    White KA, Lange EM, Ray AM, Wojno KJ, Cooney KA.
    Prostate Cancer Prostatic Dis; 2006 Jan 01; 9(3):298-302. PubMed ID: 16733518
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.